Study: Continuous Blood Sugar Monitor Best
Posted on: Wednesday, 10 September 2008, 18:00 CDT
A U.S. study has determined type 1 diabetes patients using continuous glucose monitoring improved their HbA1c blood sugar control levels.
The Juvenile Diabetes Research Foundation International-funded trial showed type 1 diabetes patients using continuous glucose monitoring, or CGM, devices experienced significant improvements in HbA1c blood sugar control. HbA1c is a form of hemoglobin that's used to identify the average plasma glucose concentration in a patient's blood during prolonged periods of time.
Researchers said blood sugar control improvement was greatest for CGM patients 25 years or older, whose HbA1c levels decreased during the study by an average of 0.53 percent, as compared with .001 percent for control patients.
"These results are very important, because they show continuous glucose monitors are more than simply devices of convenience for people with diabetes -- they are tools that can substantially improve blood sugar control when used regularly," said Dr. Aaron Kowalski, director for metabolic control at JDRF.
Study results were presented this week in Rome during a meeting of the European Association for the Study of Diabetes. Portions of the data will appear in the Oct. 2 issue of the New England Journal of Medicine and are now available at nejm.org.
Source: United Press International
Related Articles
- SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia
- JDRF Study Results Show Continuous Glucose Monitoring Provides Significant Benefits in Management of Type 1 Diabetes
- ONGLYZA(TM) (Saxagliptin) Demonstrated Significant Improvements Across Key Measures of Glucose Control When Added to a Sulfonylurea or Thiazolidinedione in People With Inadequately Controlled Type 2 Diabetes
- Ablynx Announces Initiation of a Phase Ib Study in Patients for Alx-0081 and Provides a Business Update for the First Quarter 2008
- Results From Largest Statin Study of Patients With Alzheimer's Disease Show Lipitor(R) Has No Significant Impact on Disease
- Diabetes Prevention Trial Enrolls First Patients; Study Seeks Additional Volunteers in California, Texas, Louisiana
- Web Seminar Offered -- ''EHR Case Study: Delivering Patient Data Today''
- Study Results Show Diachrome(R) Improves Poorly-Controlled Blood Sugar Levels for People on Antidiabetic Prescription Medications; Findings Presented at 41st Annual Meeting of the European Association for the Study of Diabetes
- Undiagnosed High Blood Pressure Commonly Found in ER Patients
- IL-1 Trap Shows Positive Results in Study of Patients With Inflammatory Disease
 |
 |
User Comments (0)
RSS Feeds